Indiana University-Purdue University Indianapolis, Department of Psychology, 402 N. Blackford St., LD 124, Indianapolis, IN 46202, USA; University of Illinois at Chicago, Department of Psychiatry, 1747 West Roosevelt Road, 279, Chicago, IL 60608, USA.
Indiana University-Purdue University Indianapolis, Department of Psychology, 402 N. Blackford St., LD 124, Indianapolis, IN 46202, USA.
Schizophr Res. 2019 Apr;206:27-36. doi: 10.1016/j.schres.2018.10.010. Epub 2018 Dec 19.
Motivation and negative symptom research has recently been hampered by a series of inconsistent findings, leading to calls for a greater consensus on the type of measures used across studies. To inform this issue, we conducted a meta-analysis that quantified the association between motivation measures (self-report, performance-based) and clinician-rated negative symptom measures as well as a series of moderator analyses to develop a greater understanding of the measurement factors impacting this relationship. Forty-seven eligible studies with people with schizophrenia-spectrum disorders were included. Using a random-effects meta-analytic model, a small but significant overall effect size emerged between motivation and clinician-rated negative symptoms (r = -0.18). Several significant moderators were identified, including the generation of negative symptom measures such that there was a significantly stronger relationship between motivation and second-generation (r = -0.38) than first-generation negative symptom measures (r = -0.17). Further, the type of performance-based measure used moderated the relationship, with effort discounting tasks most strongly related to negative symptoms (r = -0.44). The domain of motivation assessed (intrinsic, extrinsic, amotivation) also moderated the relationship. These findings help to identify sources of inconsistencies observed in prior studies and point to both second-generation and effort discounting tasks as the most promising types of measures, particularly for those interested in validating motivation measures or assessing the effectiveness of motivation treatments. Although additional research is needed, our results suggest that using these measures may help to reduce inconsistencies across studies and move the field forward.
动机和阴性症状研究最近受到一系列不一致发现的阻碍,这导致人们呼吁在研究中使用的测量类型上达成更大的共识。为了解决这个问题,我们进行了一项荟萃分析,量化了动机测量(自我报告、基于表现的)与临床医生评定的阴性症状测量之间的关联,以及一系列的调节分析,以更深入地了解影响这种关系的测量因素。共纳入了 47 项符合条件的精神分裂症谱系障碍患者研究。使用随机效应荟萃分析模型,动机与临床医生评定的阴性症状之间出现了一个小但显著的总体效应量(r= -0.18)。确定了几个显著的调节因素,包括负面症状测量的生成,即动机与第二代(r= -0.38)的关系明显强于第一代(r= -0.17)。此外,所使用的基于表现的测量类型也调节了这种关系,努力折扣任务与负面症状的相关性最强(r= -0.44)。评估的动机领域(内在、外在、动机缺乏)也调节了这种关系。这些发现有助于确定先前研究中观察到的不一致的来源,并指出第二代和努力折扣任务是最有前途的测量类型,特别是对于那些有兴趣验证动机测量或评估动机治疗效果的人。尽管还需要进一步的研究,但我们的结果表明,使用这些测量方法可能有助于减少研究之间的不一致,并推动该领域的发展。